ClinicalTrials.Veeva

Menu

The Need for Luteal Support in NC-FET

W

Wolfson Medical Center (WMC)

Status and phase

Unknown
Early Phase 1

Conditions

Abnormal Menstrual Cycle

Treatments

Drug: Vaginal tablet Endometrin twice a day

Study type

Interventional

Funder types

Other

Identifiers

NCT01483365
0087-11-WOMC-

Details and patient eligibility

About

The investigators are going to examine prospectively the need of luteal support after NC-FET.

Full description

The investigators are going to examine retroprospectively the need of luteal support after NC-FET in IVF cycle. One arm will receive luteal support after NC FET with vaginal tablet of Endometrin 100 mg twice a day after ET. The second arm will not. We are going to evaluate the pregnancy and implantation rate.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women under 39 years old, regular menstruation going through IVF NC-FET

Exclusion criteria

  • NO

Trial contacts and locations

1

Loading...

Central trial contact

Eran Horowitz, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems